We are a group of motivated immunologists and oncologists committed to delivering the power of cytokines to patients.

Founded in 2017 by leading experts in the field of immunotherapy, Anaveon is a biopharmaceutical company that specializes in the development of treatments for diseases with immune system dysfunction.

Our goal is to harness the power of engineered cytokines and develop novel treatments for diseases with high unmet need.

Years of Experience

Million CHF Funding

Growing team


Our dedicated team of experts has decades of experience in immunology, oncology and drug design. We use our deep knowledge to deliver novel drugs that address unmet medical needs.

About us

We are committed to developing treatments that benefit patients.


We are developing an IL-2 immunotherapy for cancer.


We are driven by the urgency of patients.


We are backed by more than 146 million CHF of funding.